Risk & Reward w/ Dr. Jonathan Hill
Listen now
Description
Bill and Dr. Jonathan Hill had a conversation about Jonathan's professional journey in the medical field, including his experiences training in Scotland, London, and the US. They discussed his current focus on molecular biology and stem cell research, his interest in treating patients with CTO's, and his research on angiogenesis. They also talked about Jonathan's shift from stem cell research to focusing on CTO's, the importance of being open to new opportunities and experiences, and the financial challenges faced by interventional cardiologists in the UK. 
More Episodes
Join us as we sit down with Mike Minogue, whose story is as impactful as it is instructional. He is the President and CEO of Minogue Consulting, LLC. He served as Chairman, President and Chief Executive Officer of Abiomed, Inc., for 18 years until its acquisition in December 2022 by Johnson...
Published 05/31/24
Published 05/31/24
Prepare to have your perspective on the interplay between industry-sponsored clinical trials and physician decision-making profoundly expanded. Esteemed interventional cardiologist Hemal Gada, MD joins me to scrutinize the nuanced influence of industry partnerships in healthcare and the ethical...
Published 05/24/24